DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Clinical safety rating: caution
Comprehensive clinical and safety monograph for DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER).
Dianeal PD-1 with Dextrose 1.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the peritoneal cavity via diffusion and ultrafiltration.
| Metabolism | Dextrose is absorbed systemically and metabolized via glycolysis and oxidative pathways; the solution itself is not metabolized. |
| Excretion | Renal: dialysis (peritoneal) accounts for >95% of dextrose elimination; minimal renal excretion (<5% unchanged dextrose). Biliary/fecal: negligible. |
| Half-life | Dextrose half-life is approximately 1-2 hours in normal individuals; with peritoneal dialysis, elimination is governed by dialysate dwell time and peritoneal transport characteristics, typically 4-6 hours for complete absorption. |
| Protein binding | Dextrose exhibits negligible protein binding (<5%) due to its small molecular size and hydrophilicity. |
| Volume of Distribution | Approximately 0.2-0.3 L/kg for dextrose (total body water), reflecting rapid equilibration throughout extracellular and intracellular fluid. |
| Bioavailability | Intraperitoneal: 100% (administered directly into peritoneal cavity, absorbed systemically via peritoneal capillaries). Oral/IV: not relevant for this formulation. |
| Onset of Action | Intraperitoneal: osmotic effect begins within 15-30 minutes of instillation. |
| Duration of Action | Intraperitoneal: 4-6 hours (dwell time) for optimal ultrafiltration; longer dwells may lead to decreased efficiency. |
2 L intraperitoneally via continuous ambulatory peritoneal dialysis (CAPD) four times daily, with dwell times of 4-6 hours each. For automated peritoneal dialysis (APD), 2 L per cycle with 4-5 cycles overnight.
| Dosage form | SOLUTION |
| Renal impairment | No dose adjustment required for peritoneal dialysis solutions; they are specifically used for renal replacement therapy. Not applicable for non-dialysis patients. |
| Liver impairment | No specific adjustment based on Child-Pugh score. Caution in severe hepatic failure due to potential for lactate accumulation; monitor serum lactate levels. |
| Pediatric use | Weight-based: 800-1100 mL/m² body surface area per exchange, typically 4-5 exchanges per day for CAPD. For APD, cycle volumes of 25-45 mL/kg per cycle, with 4-6 cycles overnight. Adjust based on clinical and metabolic response. |
| Geriatric use | No specific dose adjustment. Consider reduced clearance in elderly patients; monitor fluid balance, electrolytes, and nutritional status closely. Lower initial volumes (e.g., 1.5 L) may be used to minimize intra-abdominal pressure. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER).
| Breastfeeding | Dextrose and electrolytes pass into breast milk only in trace amounts due to minimal systemic absorption. The M/P ratio is not applicable. Use is considered compatible with breastfeeding. |
| Teratogenic Risk | Dianeal PD-1 with dextrose 1.5% is not a systemically absorbed drug; it is a peritoneal dialysis solution. There is no known teratogenic risk from the constituents (dextrose, electrolytes) at therapeutic concentrations. However, maternal uremia itself is associated with fetal risks. No specific trimester risks are documented. |
■ FDA Black Box Warning
Not for intravenous use. Peritoneal dialysis solutions are for intraperitoneal administration only.
| Serious Effects |
["Pre-existing severe hypokalemia","Pre-existing hyperglycemia or diabetes with poor control","Documented hypersensitivity to dextrose or any component","Abdominal conditions compromising peritoneal integrity (e.g., recent surgery, hernia, bowel obstruction)","Severe lactic acidosis or other metabolic acidosis"]
| Precautions | ["Peritonitis risk","Catheter-related complications (e.g., leakage, obstruction)","Fluid and electrolyte imbalances (hypokalemia, hyperglycemia, hypernatremia)","Protein loss requiring nutritional supplementation","Hypersensitivity reactions to dextrose or solution components"] |
| Food/Dietary | No direct food interactions. However, because the solution contains dextrose that is absorbed systemically, a low-glycemic diet may help manage blood glucose levels. Avoid high-sugar foods and beverages, especially in diabetic patients. Maintain a balanced diet with appropriate protein and fluid restrictions as advised by the renal dietitian. |
Loading safety data…
| Fetal Monitoring | Monitor maternal serum electrolytes, glucose, urea, creatinine, and acid-base status. Fetal monitoring includes ultrasound for growth and amniotic fluid volume, and nonstress testing in third trimester. |
| Fertility Effects | No direct effects on fertility from the solution. Underlying renal disease may impair fertility. |
| Clinical Pearls | Dianeal PD-1 with 1.5% dextrose is a peritoneal dialysis solution used in continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD). Monitor serum glucose closely in diabetic patients as dextrose absorption may cause hyperglycemia. Use caution in patients with severe lactic acidosis or severe hyperglycemia. Ensure proper aseptic technique to prevent peritonitis. Check effluent for clarity and turbidity; cloudy effluent may indicate infection. |
| Patient Advice | Inspect the solution bag for leaks, cloudiness, or discoloration before use; do not use if present. · Warm the solution to body temperature (37°C) prior to infusion to reduce discomfort. · Use strict sterile technique when connecting and disconnecting lines to prevent infection. · Record the weight of the drained effluent; report any significant changes or persistent cloudiness. · Report symptoms of infection such as abdominal pain, fever, or cloudy dialysis fluid immediately. · Monitor blood sugar levels regularly if you have diabetes, as the dextrose in the solution can raise blood sugar. · Do not reuse any single-use equipment or solutions. · Store unused solution at room temperature (15-30°C); avoid excessive heat or freezing. |